[1] SUMMERS L,ULOTH R H. Reaction of bis-(cyclopentadieny)- titanium dichloride with aryllithium compounds[J]. J. Am. Chem. Soc.,1954,76(8):2278-2279. [2] 徐炽焕. 国外茂金属催化剂的最新进展[J]. 化工进展,1996,15(4):1-4. [3] 孔媛,马利福,黄启谷,等. 茂金属化合物催化极性烯类单体活性聚合的研究进展[J]. 化工进展,2009,28(2):243-250 [4] 孙琪,廖世健,徐筠,等. Cp2TiC12/n-BuLi催化体系在烯烃加氢反应中的催化活性和稳定性[J]. 催化学报,1997,18(2):147-151. [5] ROSENTHAL U,BURLAKO V V. Organometallic chemistry of titanocene and zirconocene complexes with bis(trimethysilyl) acetylene as the basis for applications in organic synthesis[J]. Titanium and Zirconium in Organic Synthesis,2002,28:355-389. [6] KÖPF-MAIER P,KÖPF H,WAGNER W. Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides[J]. Naturwissenschaften,1981,68(5):272. [7] 艾海马,周耀坤,周梅华. 环戊二烯基氟尿嘧啶基钛(Ⅳ),锆(Ⅳ)配合物的合成及其抗肿瘤活性的研究[J]. 高等学校化学学报,1994,15(8):1119-1123. [8] KÖPF H,KÖPF-MAIER P. Titanocene dichloride—the first metallocene with cancerostatic activity[J]. Angew Chem. Int. Ed. Engl.,1979,18(6):477-478. [9] KOSTOVA I. Titanium and vanadium complexes as anticancer agents[J]. Anti-Cancer Agents Med. Chem.,2009,9:827-842. [10] 赵立芳,耿启辉. 二茂钛在水溶液和非水溶剂中电导行为的研究[J]. 新疆大学学报,1989,6(4):71-74. [11] MELÉNDEZ E. Titanium complexes in cancer treatment[J]. Critical Reviews in Oncology/Hematology,2002,42:309-315. [12] TSHUVA E Y,PERI D. Modern cytotoxic titanium(Ⅳ) complexes; Insights on the enigmatic involvement of hydrolysis[J]. Coord. Chem. Rev.,2009,253:2098-2115. [13] PERI D,MEKER S,SHAVIT M,et al. Synthesis,characterization,cytotoxicity,and hydrolytic behavior of C2- and C1-symmetrical TiIV complexes of tetradentate diamine bis(phenolato) ligands:a new class of antitumor agents[J]. Chem. Eur. J.,2009,15:2403-2415. [14] PERI D,MEKER S,MANNA C M,et al. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) “salan” Ti(Ⅳ) complexes[J]. Inorg. Chem.,2011,50:1030-1038. [15] PERI D,MANNA C M,SHAVIT M,et al. TiIV Complexes of branched diamine bis(phenolato) ligands:hydrolysis and cytotoxicity[M]. Weinheim:Wiley-VCH Verlay GmbH & Co. KGaA,2011. [16] PÉREZ Y,LÓPEZ V,RIVERA-RIVERA L,et al. Water-soluble titanocene complexes with sulfur-containing aminoacids:synthesis,spectroscopic,electrochemical and Ti(Ⅳ)-transferrin interaction studies[J]. J. Biol. Inorg. Chem.,2005,10:94-104. [17] HERNÁNDEZ R,LAMBOY J,GAO L M,et al. Structure-activity studies of Ti(Ⅳ) complexes:aqueous stability and cytotoxic properties in colon cancer HT-29 cells[J]. J. Biol. Inorg. Chem.,2008,13:685-692. [18] CEBALLOS-TORRES J,HIERRO I D,PRASHAR S,et al. Alkenyl-substituted titanocene dichloride complexes:stability studies,binding and cytotoxicity[J]. J. Organomet. Chem.,2014,769:46-57. [19] TINOCO A D,EAMES E V,INCARVITO C D,et al. Hydrolytic metal with a hydrophobic periphery:titanium(Ⅳ) complexes of naphthalene-2,3-diolate and interactions with serum albumin[J]. Inorg. Chem.,2008,47:8380-8390. [20] BARROSO S,COELHO A M,GÓMEZ-RUIZ S,et al. Synthesis,cytotoxic and hydrolytic studies of titanium complexes anchored by a tripodal diamine bis(phenolate) ligand[J]. Dalton Trans.,2014,43:17422-17433. [21] TINOCO A D,INCARVITO C D,VALENTINE A M. Calorimetric,spectroscopic,and model studies provide insight into the transport of Ti(Ⅳ) by human serum transferrin[J]. J. Am. Chem. Soc.,2007,129:3444-3454. [22] TONEY J H,MARKS T J. Hydrolysis chemistry of the metallocene dichloridesM(η5-C5H5)2C12,M=Ti,V,Zr. aqueous kinetics,equilibria,and mechanistic implications for a new class of antitumor agents[J].J. Am. Chem. Soc.,1985,107:947-953. [23] GUO Maolin,GUO Zijian,SADLER P J. Titanium(Ⅳ) targets phosphoesters on nucleotides:implications for the mechanism of action of the anticancer drug titanocene dichloride[J]. J. Biol. Inorg. Chem.,2001,6:698-707. [24] ERXLEBEN A,CLAFFEY J,TACKE M. Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters[J].J. Inorg. Biochem.,2010,104:390-396. [25] WAERN J B,TURNER P,HARDING M M. Synthesis and hydrolysis of thiol derivatives of molybdocene dichloride incorporating electron-withdrawing substituents[J]. Organometallics.,2006,25:3417-3421. [26] MURRAY J H,HARDING M M. Organometallic anticancer agents:the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents[J]. J. Med. Chem.,1994,37:1936-1941. [27] SONG Z,HSIEH Y,KANNO K,et al. Coupling reaction of a cyclopentadienyl ligand with a dienyl or alkenyl moiety on titanocene[J]. Organometallics,2011,30:844-851. [28] CARUSO F,ROSSIB M. Coupling reaction of a cyclopentadienyl ligand with a dienyl or alkenyl moiety on titanocene[J]. Mini-Rev. Med. Chem.,2004,4:49-60. [29] 赵立芳,耿启辉. 二卤二茂钛在水溶液中的水解化学[J]. 化学研究与应用,1991,3(3):80-85. [30] CHEN X,ZHOU L X. The hydrolysis chemistry of anticancer drug titanocene dichloride:an insight from theoretical study[J]. J. Mol. Struct-Theochem.,2010,940:45-49. [31] SUÁREZ D,ZAKARIANEZHAD M,LÓPEZ R. Insights into the hydrolytic chemistry of molybdocene dichloride based on a theoretical mechanistic study[J]. Theor. Chem. Acc.,2013,132:1409. [32] 梅泽民. 茂金属化合物电子结构与催化活性关系的研究[D]. 长春:吉林大学,2006. |